Australian Meningococcal Surveillance Programme, 1 January to 31 March 2016

The Australian Meningococcal Surveillance Programme monitors anticrobial resistance in the treatments for meningococcal infection. This quarterly report describes the results for the period 1 January to 31 March 2016.

Page last updated: 30 September 2016

Monica M Lahra, Rodney P Enriquez for the Australian Meningococcal Surveillance Programme

Introduction

The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases confirmed by laboratory testing using culture and by non-culture based techniques. Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification assays and serological techniques, are defined as invasive meningococcal disease (IMD) according to Public Health Laboratory Network definitions. Data contained in quarterly reports are restricted to a description of the number of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received. A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the AMSP annual reports published in Communicable Diseases Intelligence. For more information see Commun Dis Intell 2016;40(1):E13.

Results

Laboratory confirmed cases of invasive meningococcal disease for the period 1 January to 31 March 2016 are shown in the Table.

Table: Number of laboratory confirmed cases of invasive meningococcal disease, Australia, 1 January to 31 March 2016, by serogroup and state or territory
State or territory Year Serogroup
A B C Y W135 ND All
Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD
Australian Capital Territory 2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2015 0 0 0 0 0 0 0 0 0 0 0 0 0 0
New South Wales 2016 0 0 5 5 1 1 1 1 4 4 2 2 13 13
2015 0 0 3 3 1 1 0 0 1 1 0 0 5 5
Northern Territory 2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2015 0 0 1 1 0 0 0 0 0 0 0 0 1 1
Queensland 2016 0 0 3 3 0 0 4 4 2 2 2 2 11 11
2015 0 0 5 5 0 0 1 1 0 0 0 0 6 6
South Australia 2016 0 0 6 6 0 0 0 0 0 0 0 0 6 6
2015 0 0 2 2 0 0 0 0 0 0 0 0 2 2
Tasmania 2016 0 0 0 0 0 0 0 0 2 2 0 0 2 2
2015 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Victoria 2016 0 0 3 3 1 1 0 0 6 6 0 0 10 10
2015 0 0 8 8 0 0 0 0 1 1 0 0 9 9
Western Australia 2016 0 0 1 1 0 0 0 0 2 2 0 0 3 3
2015 0 0 2 2 0 0 0 0 0 0 0 0 2 2
Total 2016 0 0 18 18 2 2 5 5 16 16 4 4 45 45
2015 0 0 21 21 1 1 1 1 2 2 0 0 25 25

Author details

Monica M Lahra1,2

Rodney P Enriquez 1

  1. Neisseria Reference Laboratory and World Health Organisation Collaborating Centre for STD, Sydney. Department of Microbiology, South Eastern Area Laboratory Services, The Prince of Wales Hospital, Randwick, NSW
  2. School of Medical Sciences, Faculty of Medicine, The University of New South Wales, New South Wales

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now